10-Q |
Report
| Data |
10-Q |
Nov 7, 2024 |
Sep 30, 2024 |
8-K |
Report
| Data |
8-K |
Nov 7, 2024 |
Nov 7, 2024 |
10-Q |
Report
| Data |
10-Q |
Aug 8, 2024 |
Jun 30, 2024 |
8-K |
Report
| Data |
8-K |
Aug 8, 2024 |
Aug 5, 2024 |
SC 13G/A |
Report
|
|
Jul 8, 2024 |
|
8-K |
Report
| Data |
8-K |
Jun 7, 2024 |
Jun 6, 2024 |
10-Q |
Report
| Data |
10-Q |
May 9, 2024 |
Mar 31, 2024 |
8-K |
Report
| Data |
8-K |
May 9, 2024 |
May 9, 2024 |
SC 13G/A |
Report
|
FILING PMV PHARMACEUTICALS, INC. |
Apr 9, 2024 |
|
10-K |
Report
| Data |
10-K |
Feb 29, 2024 |
Dec 31, 2023 |
8-K |
Report
| Data |
8-K |
Feb 29, 2024 |
Feb 29, 2024 |
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2024 |
|
SC 13G/A |
Report
|
|
Feb 14, 2024 |
|
SC 13G |
Report
|
|
Feb 14, 2024 |
|
SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 13, 2024 |
|
SC 13G/A |
Report
|
|
Jan 29, 2024 |
|
SC 13G/A |
Report
|
FILING PMV PHARMACEUTICALS, INC. |
Jan 23, 2024 |
|
SC 13G/A |
Report
|
|
Jan 23, 2024 |
|
8-K |
Report
| Data |
8-K |
Jan 18, 2024 |
Jan 18, 2024 |
8-K |
Report
| Data |
8-K |
Jan 5, 2024 |
Jan 4, 2024 |
10-Q |
Report
| Data |
10-Q |
Nov 9, 2023 |
Sep 30, 2023 |
8-K |
Report
| Data |
8-K |
Nov 9, 2023 |
Nov 9, 2023 |
8-K |
Report
| Data |
8-K |
Oct 12, 2023 |
Oct 12, 2023 |
8-K |
Report
| Data |
8-K |
Oct 11, 2023 |
Oct 11, 2023 |
SC 13D/A |
Report
|
AMENDMENT NO. 2 |
Aug 23, 2023 |
|
10-Q |
Report
| Data |
10-Q |
Aug 9, 2023 |
Jun 30, 2023 |
8-K |
Report
| Data |
8-K |
Aug 9, 2023 |
Aug 9, 2023 |
SC 13G/A |
Report
|
|
Jul 7, 2023 |
|
8-K |
Report
| Data |
8-K |
Jun 9, 2023 |
Jun 8, 2023 |
SC 13G |
Report
|
SC 13G |
May 19, 2023 |
|
10-Q |
Report
| Data |
10-Q |
May 10, 2023 |
Mar 31, 2023 |
8-K |
Report
| Data |
8-K |
May 10, 2023 |
May 10, 2023 |
SC 13G/A |
Report
|
|
May 10, 2023 |
|
8-K |
Report
| Data |
8-K |
Apr 28, 2023 |
Apr 24, 2023 |
10-K |
Report
| Data |
10-K |
Mar 1, 2023 |
Dec 31, 2022 |
8-K |
Report
| Data |
8-K |
Mar 1, 2023 |
Mar 1, 2023 |
SC 13G/A |
Report
|
|
Feb 14, 2023 |
|
SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 10, 2023 |
|
SC 13G/A |
Report
|
|
Feb 10, 2023 |
|
SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 9, 2023 |
|
SC 13G/A |
Report
|
|
Jan 31, 2023 |
|
SC 13G/A |
Report
|
FILING PMV PHARMACEUTICALS, INC. |
Jan 25, 2023 |
|
SC 13G/A |
Report
|
COWEN FINANCIAL PRODUCTS LLC |
Jan 24, 2023 |
|
10-Q |
Report
| Data |
10-Q |
Nov 8, 2022 |
Sep 30, 2022 |
8-K |
Report
| Data |
8-K |
Nov 8, 2022 |
Nov 8, 2022 |
8-K |
Report
| Data |
8-K |
Nov 4, 2022 |
Nov 3, 2022 |
10-Q |
Report
| Data |
10-Q |
Aug 9, 2022 |
Jun 30, 2022 |
8-K |
Report
| Data |
8-K |
Aug 9, 2022 |
Aug 9, 2022 |
SC 13G |
Report
|
|
Jul 11, 2022 |
|
SC 13G/A |
Report
|
FILING PMV PHARMACEUTICALS, INC. |
Jul 7, 2022 |
|
SC 13G |
Report
|
PMV PHARMACEUTICALS, INC. |
Jun 17, 2022 |
|
8-K |
Report
| Data |
8-K |
Jun 8, 2022 |
Jun 7, 2022 |
8-K |
Report
| Data |
8-K |
Jun 6, 2022 |
Jun 2, 2022 |
8-K |
Report
| Data |
8-K |
May 26, 2022 |
May 26, 2022 |
10-Q |
Report
| Data |
10-Q |
May 10, 2022 |
Mar 31, 2022 |
8-K |
Report
| Data |
8-K |
May 10, 2022 |
May 10, 2022 |
SC 13D/A |
Report
|
AMENDMENT NO. 1 |
Apr 1, 2022 |
|
10-K |
Report
| Data |
10-K |
Mar 1, 2022 |
Dec 31, 2021 |
8-K |
Report
| Data |
8-K |
Mar 1, 2022 |
Mar 1, 2022 |
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
SC 13G |
Report
|
SCHEDULE 13G |
Feb 10, 2022 |
|
SC 13G |
Report
|
|
Feb 4, 2022 |
|
SC 13G |
Report
|
FILING PMV PHARMACEUTICALS, INC. |
Jan 26, 2022 |
|
SC 13G |
Report
|
COWEN FINANCIAL PRODUCTS LLC |
Jan 19, 2022 |
|
8-K |
Report
| Data |
FORM 8-K |
Jan 6, 2022 |
Jan 5, 2022 |
10-Q |
Report
| Data |
10-Q |
Nov 12, 2021 |
Sep 30, 2021 |
8-K |
Report
| Data |
8-K |
Nov 12, 2021 |
Nov 12, 2021 |
SC 13G/A |
Report
|
SC 13G/A |
Oct 18, 2021 |
|
8-K |
Report
| Data |
FORM 8-K |
Oct 5, 2021 |
Oct 4, 2021 |
10-Q |
Report
| Data |
10-Q |
Aug 13, 2021 |
Jun 30, 2021 |
8-K |
Report
|
8-K |
Aug 13, 2021 |
Aug 13, 2021 |
8-K |
Report
|
8-K |
Jun 7, 2021 |
Jun 2, 2021 |
10-Q |
Report
| Data |
10-Q |
May 14, 2021 |
Mar 31, 2021 |
8-K |
Report
|
8-K |
May 14, 2021 |
May 14, 2021 |
SC 13G/A |
Report
|
SC 13G/A |
May 7, 2021 |
|
8-K |
Report
|
8-K |
Apr 6, 2021 |
Apr 1, 2021 |
10-K |
Report
| Data |
10-K |
Mar 3, 2021 |
Dec 31, 2020 |
8-K |
Report
|
8-K |
Mar 3, 2021 |
Mar 3, 2021 |
SC 13G |
Report
|
SC 13G |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 1 |
Feb 16, 2021 |
|
SC 13G |
Report
|
SC 13G |
Feb 12, 2021 |
|
SC 13G |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 12, 2021 |
|
SC 13G |
Report
|
SC 13G |
Feb 12, 2021 |
|
10-Q |
Report
| Data |
10-Q |
Nov 13, 2020 |
Sep 30, 2020 |
8-K |
Report
|
8-K |
Nov 13, 2020 |
Nov 13, 2020 |
SC 13D |
Report
|
SCHEDULE 13D |
Oct 5, 2020 |
|
SC 13G |
Report
|
ACQUISITION OF BENEFICIAL OWNERSHIP |
Oct 5, 2020 |
|
SC 13G |
Report
|
SC 13G |
Sep 30, 2020 |
|
8-K |
Report
|
8-K |
Sep 29, 2020 |
Sep 29, 2020 |